Nanocarrier Drug Conjugates Exhibit Potent Anti-Naegleria fowleri and Anti-Balamuthia mandrillaris Properties
暂无分享,去创建一个
M. R. Shah | R. Siddiqui | N. Khan | T. Anuar | Muhammad Kawish | Tooba Jabri | Anania Boghossian | Zainab Al-Shareef | M. Shah
[1] G. Wang,et al. Treatment of cutaneous Balamuthia mandrillaris infection with diminazene aceturate: a report of 4 cases. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] M. R. Shah,et al. Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials , 2022, Antibiotics.
[3] M. Witcher,et al. Successful Treatment of a Balamuthia mandrillaris Cerebral Abscess in a Pediatric Patient With Complete Surgical Resection and Antimicrobial Therapy , 2021, The Pediatric infectious disease journal.
[4] R. Siddiqui,et al. Nanovesicles containing curcumin hold promise in the development of new formulations of anti-Acanthamoebic agents. , 2021, Molecular and biochemical parasitology.
[5] S. Parija,et al. Balamuthia mandrillaris: An opportunistic, free-living ameba – An updated review , 2021, Tropical parasitology.
[6] R. Siddiqui,et al. Contemporary approaches to treat Naegleria fowleri: a patent overview. , 2021, Pharmaceutical patent analyst.
[7] L. Z. Rodriguez-Anaya,et al. Application of the omics sciences to the study of Naegleria fowleri, Acanthamoeba spp., and Balamuthia mandrillaris: current status and future projections , 2021, Parasite.
[8] P. Loiseau,et al. Drugs used for the treatment of cerebral and disseminated infections caused by free‐living amoebae , 2021, Clinical and translational science.
[9] R. Siddiqui,et al. Brain-Eating Amoebae in the United Arab Emirates? , 2021, ACS pharmacology & translational science.
[10] A. Debnath. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads , 2021, Expert review of anti-infective therapy.
[11] A. Elhissi,et al. Galactosylated iron oxide nanoparticles for enhancing oral bioavailability of ceftriaxone , 2021, Pharmaceutical development and technology.
[12] R. Siddiqui,et al. Current treatment options of Balamuthia mandrillaris: a patent overview. , 2020, Pharmaceutical patent analyst.
[13] A. Elhissi,et al. Enhancement in Oral Absorption of Ceftriaxone by Highly Functionalized Magnetic Iron Oxide Nanoparticles , 2020, Pharmaceutics.
[14] Ayaz Anwar,et al. Gold-Conjugated Curcumin as a Novel Therapeutic Agent against Brain-Eating Amoebae , 2020, ACS omega.
[15] D. Kyle,et al. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae , 2020, bioRxiv.
[16] R. Siddiqui,et al. Antibacterial Activities of Selected Pure Compounds Isolated from Gut Bacteria of Animals Living in Polluted Environments , 2020, Antibiotics.
[17] R. Siddiqui,et al. Novel Azoles as Antiparasitic Remedies against Brain-Eating Amoebae , 2020, Antibiotics.
[18] Ayaz Anwar,et al. The Use of Nanomedicine for Targeted Therapy against Bacterial Infections , 2019, Antibiotics.
[19] J. Lorenzo-Morales,et al. Is Naegleria fowleri an Emerging Parasite? , 2019, Trends in parasitology.
[20] Z. Kong,et al. Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells , 2019, International journal of molecular sciences.
[21] K. Rajendran,et al. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri. , 2019, ACS chemical neuroscience.
[22] K. Rajendran,et al. Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids , 2019, Scientific Reports.
[23] Suresh Thareja,et al. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery , 2019, Artificial cells, nanomedicine, and biotechnology.
[24] B. L. C. Gondim,et al. Nanoparticle-mediated drug delivery: blood-brain barrier as the main obstacle to treat infectious diseases in CNS. , 2019, Current pharmaceutical design.
[25] Shafiullah,et al. Fabrication of lecithin-gum tragacanth muco-adhesive hybrid nano-carrier system for in-vivo performance of Amphotericin B. , 2018, Carbohydrate polymers.
[26] M. R. Shah,et al. Cytotoxic effects of Benzodioxane, Naphthalene diimide, Porphyrin and Acetamol derivatives on HeLa cells , 2018, SAGE open medicine.
[27] K. Rajendran,et al. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri. , 2017, ACS chemical neuroscience.
[28] Zhengyu Jin,et al. Linear dextrin as curcumin delivery system: Effect of degree of polymerization on the functional stability of curcumin , 2017 .
[29] A. Olender,et al. Human infections caused by free-living amoebae. , 2017, Annals of agricultural and environmental medicine : AAEM.
[30] R. Siddiqui,et al. Brain-Eating Amoebae: Predilection Sites in the Brain and Disease Outcome , 2017, Journal of Clinical Microbiology.
[31] H. Tenhu,et al. Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering , 2017, Nanoscale Research Letters.
[32] R. Siddiqui,et al. Biology and pathogenesis of Naegleria fowleri. , 2016, Acta tropica.
[33] Gareth R Williams,et al. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. , 2016, Carbohydrate polymers.
[34] K. Kokko,et al. Transmission of Balamuthia mandrillaris by Organ Transplantation. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] L. Gonçalves,et al. NANOBIOCATALYTIC SYSTEMS BASED ON LIPASE-Fe3O4 AND CONVENTIONAL SYSTEMS FOR ISONIAZID SYNTHESIS: A COMPARATIVE STUDY , 2016 .
[36] I. Hussain,et al. Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein-In-vitro and in-vivo study. , 2016, Colloids and surfaces. B, Biointerfaces.
[37] Kristopher G. Virga,et al. Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options , 2015, Antimicrobial Agents and Chemotherapy.
[38] M. Mahmoudi,et al. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. , 2013, Nanoscale.
[39] A. Ayadi,et al. Pathogenic free-living amoebae: epidemiology and clinical review. , 2012, Pathologie-biologie.
[40] R. Siddiqui,et al. Anti-Acanthamoebic properties of resveratrol and demethoxycurcumin. , 2012, Experimental parasitology.
[41] Rupesh Kumar Basniwal,et al. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. , 2011, Journal of agricultural and food chemistry.
[42] O. Kayser,et al. Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[43] R. Siddiqui,et al. Increasing Importance of Balamuthia mandrillaris , 2008, Clinical Microbiology Reviews.
[44] F. Schuster,et al. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. , 2007, FEMS immunology and medical microbiology.
[45] F. Schuster. Cultivation of Pathogenic and Opportunistic Free-Living Amebas , 2002, Clinical Microbiology Reviews.
[46] S. Sarker,et al. Pyranoisoflavones from Rinorea welwitschii. , 2000, Fitoterapia.